MX9710523A - Vacunas contra hepatitis c. - Google Patents

Vacunas contra hepatitis c.

Info

Publication number
MX9710523A
MX9710523A MX9710523A MX9710523A MX9710523A MX 9710523 A MX9710523 A MX 9710523A MX 9710523 A MX9710523 A MX 9710523A MX 9710523 A MX9710523 A MX 9710523A MX 9710523 A MX9710523 A MX 9710523A
Authority
MX
Mexico
Prior art keywords
oil
hepatitis
vaccines against
against hepatitis
water emulsion
Prior art date
Application number
MX9710523A
Other languages
English (en)
Other versions
MXPA97010523A (es
Inventor
Teresa Cabezon Silva
Patricia Marie Momin
Nathalie Marie Josephe Claude
Garcon
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of MX9710523A publication Critical patent/MX9710523A/es
Publication of MXPA97010523A publication Critical patent/MXPA97010523A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/29Hepatitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08RNA viruses
    • C07K14/18Togaviridae; Flaviviridae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55572Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55577Saponins; Quil A; QS21; ISCOMS
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6075Viral proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24211Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una composicion de vacuna comprende QS21, Lípido A monofosforil 3 De-O-acilado (3D-MPL), una emulsion de aceite en agua, en donde la emulsion de aceite en agua tiene la siguiente composicion; un aceite metabolizable, tal como escualeno, alfa tocoferol y tween 80. Y por lo menos un inmunogeno seleccionado del grupo que consiste de (a) una proteína de nucleo de virus de hepatitis C o un derivado inmunogenico de la misma, y (b) una proteína de envoltura de virus de hepatitis C o un derivado inmunogénico de la misma.
MXPA/A/1997/010523A 1995-06-29 1997-12-19 Vacunas contra hepatitis c MXPA97010523A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9513261.9A GB9513261D0 (en) 1995-06-29 1995-06-29 Vaccines
GB9513261.9 1995-06-29

Publications (2)

Publication Number Publication Date
MX9710523A true MX9710523A (es) 1998-09-30
MXPA97010523A MXPA97010523A (es) 1998-11-16

Family

ID=

Also Published As

Publication number Publication date
GB9513261D0 (en) 1995-09-06
TR199701713T1 (xx) 1998-05-21
PL324906A1 (en) 1998-06-22
WO1997001640A3 (en) 1997-05-15
AU6304996A (en) 1997-01-30
EP0835318A2 (en) 1998-04-15
IL122589A0 (en) 1998-06-15
BR9609258A (pt) 1999-05-11
CA2222456A1 (en) 1997-01-16
CZ422397A3 (cs) 1998-06-17
KR19990028505A (ko) 1999-04-15
HUP9901901A2 (hu) 1999-09-28
HUP9901901A3 (en) 2000-03-28
WO1997001640A2 (en) 1997-01-16
JPH11508769A (ja) 1999-08-03
NO976060L (no) 1998-02-17
ZA965459B (en) 1997-04-01
NO976060D0 (no) 1997-12-23

Similar Documents

Publication Publication Date Title
WO1997001640A3 (en) Vaccines against hepatitis c
MY134811A (en) A vaccine composition comprising an antigen, a saponin and a sterol
CA2302554A1 (en) Oil in water emulsions containing saponins
HUP9903169A3 (en) Low pathogenicity prrs live virus vaccines and methods of preparation thereof
UA40597C2 (uk) Вакцинна композиція,спосіб лікування ссавців, що страждають або сприйнятливі до інфекції, спосіб лікування ссавців, що страждають на рак, спосіб одержання вакцинної композиції, композиція ад'ювантів
GB2303855B (en) Helicobacter pylori antigenic protein preparation and immunoassays
LU91486I2 (fr) Emulsion huile-dans-eau comprenant du squalène, duDL-a-tocophérol et du polysorbate 80
EP0835133A4 (en) RECOMBINANT COMPOSITIONS AND COMBINED COMPOSITIONS OF RABIES AND SMALLPOX VIRUSES, AND USES THEREOF
DK0745387T3 (da) Adjuvanser til virale vacciner
AU6093296A (en) Infectious dengue 2 virus pdk-53 as quadravalent vaccine
PT98156A (pt) Um processo de preparacao de uma composicao de vacina
ZA936629B (en) Potentiation of immunogenic response
PT957935E (pt) Vacinas e composicoes imunogenicas contra clamidia contendo um antigenio de membrana externa e metodos para a sua preparacao
DE3473825D1 (en) Method of preparing adjuvanted live vaccines and adjuvanted live vaccines thus obtained
DK0792165T3 (da) Immunogene præparater
BR9704879A (pt) Composição de vacina e uso de um vírus cav vivo
CA2352563A1 (en) Method to produce inactivated w/o emulsion adjuvanted vaccines
WO2002024147A3 (en) Avian pneumovirus vaccine
IL102297A0 (en) Marek's disease vaccine
CO5090912A1 (es) COMBINACION NOVEDOSA DE VACUNAS COMPRENDIENDO UN POLISACARI- DO Vi Salmonella typhi PURIFICADA Y POR LO MENOS OTRO ANTIGE NO Y METODOS PARA HACER LAS VACUNAS